Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It was another busy week for Australia's top brokers. This has led to the release of a number of broker notes.

Three broker buy ratings that you might want to know more about are summarised below. Here's why brokers think these ASX shares are in the buy zone:

Two brokers analysing stocks.

Image source: Getty Images

CSL Ltd (ASX: CSL)

According to a note out of Morgan Stanley, its analysts have retained their overweight rating and $303.00 price target on this biotherapeutics company's shares. This follows news that CSL has received US Food & Drug Administration (FDA) approval for its Andembry therapy. This product aims to help prevent attacks of hereditary angioedema (HAE). While Morgan Stanley was pleased with the news, the broker was expecting its approval and had already factored it into its forecasts. Outside this, Morgan Stanley is forecasting low-teen annual earnings growth through to FY 2028. But it sees potential to accelerate this growth through a combination of lower costs and share buybacks. The CSL share price ended last week at $240.21.

Life360 Inc (ASX: 360)

Another note out of Morgan Stanley reveals that its analysts have retained their overweight rating on this location technology company's shares with an increased price target of $40.00. According to the note, the broker believes that Life360 is well-positioned to deliver further strong growth over the medium term. It highlights that it has one of the fast-growing userbases and is supported by the network effect and word of mouth. The latter should be supportive of lower customer acquisition costs compared to what other companies have to pay. Overall, in light of the above, the broker sees potential for Life360 to outperform the market's expectations in the medium term. The Life360 share price was fetching $31.94 at the end of last week.

Zip Co Ltd (ASX: ZIP)

Analysts at Ord Minnett have retained their buy rating on this buy now pay later provider's shares with an increased price target of $3.40. According to the note, the broker believes that Zip is in a great place right now following its second guidance update in less than three months. Ord Minnett is particularly pleased with the strong momentum that is being seen in the United States market. This is despite operating in a challenging macro environment. Together with the benefits of falling interest rates, the broker feels very positive about the company's outlook and believes it strong form can continue. The Zip share price was trading at $2.87 when the market closed on Friday.

Motley Fool contributor James Mickleboro has positions in CSL and Life360. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL, Life360, and Zip Co. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A young man goes over his finances and investment portfolio at home.
Broker Notes

Buy, hold, sell: BHP, CSL, and HUB24 shares

Here's what Morgans is saying about these popular shares this week.

Read more »

Time to sell written on a clock.
Broker Notes

Sell alert! Why this expert is calling time on Xero and Northern Star shares

A leading expert forecasts ongoing headwinds for Xero and Northern Star shares. But why?

Read more »

A business person directs a pointed finger upwards on a rising arrow on a bar graph.
Broker Notes

Up 118%! Are PLS shares now a buy, hold or sell?

A leading expert provides his outlook for PLS' surging shares.

Read more »

Happy investor on tablet with finance graphs rising in overlay.
Broker Notes

Buy, hold, sell: ANZ Bank, Iress, and JB Hi-Fi shares

Here's what Morgans thinks of these shares following recent updates.

Read more »

A man casually dressed looks to the side in a pensive, thoughtful manner with one hand under his chin, and holding a mobile phone in his other hand.
Broker Notes

Is the CSL share price in the buy zone after the biotech giant's results?

Is the biotech giant a buy following its results release?

Read more »

ASX 200 bank share trading depicted by red buy and sell dice tumbling across a sheet of data in colourful graphics
Broker Notes

With $30 billion in FY26 income, should I buy CBA shares today?

A leading analyst digs into the outlook for CBA’s slipping shares.

Read more »

Woman and man calculating a dividend yield.
Broker Notes

Buy, hold, sell: REA, Northern Star Resources, Suncorp shares

Two experts share their views on three ASX 200 shares.

Read more »

Two female executives looking at a clipboard together.
Broker Notes

Buy, hold, sell: Centuria Industrial REIT, Endeavour, Wildcat Resources shares

Experts share their views on the lithium miner, hotels operator, and industrial ASX REIT.

Read more »